(Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 19.69%1.75B | -13.09%6.32B | -17.85%4.64B | -19.29%3.02B | -20.61%1.46B | 33.62%7.27B | 46.31%5.65B | 53.00%3.75B | 66.89%1.84B | 39.32%5.44B |
Operating income | 19.69%1.75B | -13.09%6.32B | -17.85%4.64B | -19.29%3.02B | -20.61%1.46B | 33.62%7.27B | 46.31%5.65B | 53.00%3.75B | 66.89%1.84B | 39.32%5.44B |
Cost of sales | -30.48%-1.51B | -13.13%-5.1B | -8.55%-3.7B | -7.00%-2.4B | -6.04%-1.16B | -19.76%-4.51B | -24.42%-3.41B | -25.20%-2.24B | -27.90%-1.09B | -26.16%-3.77B |
Operating expenses | -30.48%-1.51B | -13.13%-5.1B | -8.55%-3.7B | -7.00%-2.4B | -6.04%-1.16B | -19.76%-4.51B | -24.42%-3.41B | -25.20%-2.24B | -27.90%-1.09B | -26.16%-3.77B |
Gross profit | -21.32%239.7M | -55.91%1.22B | -57.97%942.79M | -58.61%621.17M | -59.39%304.67M | 64.80%2.76B | 99.73%2.24B | 129.08%1.5B | 199.97%750.26M | 81.97%1.68B |
Selling expenses | ---- | -6.88%-36.16M | 6.80%-17.36M | 6.80%-17.36M | ---- | -22.40%-33.83M | -54.81%-18.63M | -54.81%-18.63M | ---- | 6.19%-27.64M |
Administrative expenses | ---- | 2.32%-482.26M | 3.47%-206.31M | 3.47%-206.31M | ---- | -79.08%-493.73M | -113.86%-213.72M | -113.86%-213.72M | ---- | -3.50%-275.7M |
Research and development expenses | ---- | 3.52%-707.28M | 2.11%-345.3M | 2.11%-345.3M | ---- | -14.75%-733.1M | -17.85%-352.75M | -17.85%-352.75M | ---- | 5.69%-638.84M |
Impairment and provision | ---- | 307.44%1.26M | -332.32%-230K | -332.32%-230K | ---- | -160.68%-605K | 148.06%99K | 148.06%99K | ---- | 601.01%997K |
-Other impairment is provision | ---- | 307.44%1.26M | -332.32%-230K | -332.32%-230K | ---- | -160.68%-605K | 148.06%99K | 148.06%99K | ---- | 601.01%997K |
Special items of operating profit | -7.19%-237.3M | 8.69%364.45M | -17.67%-123.12M | -30.41%111.12M | -3.31%-221.39M | -49.04%335.3M | -140.09%-104.62M | -61.87%159.67M | -70.78%-214.28M | 80.52%657.98M |
Operating profit | -97.11%2.41M | -80.51%357.75M | -83.88%250.47M | -84.84%163.08M | -84.46%83.28M | 31.82%1.84B | 59.73%1.55B | 62.35%1.08B | 330.01%535.97M | 346.41%1.39B |
Financing income | ---- | 110.98%736.59M | 193.76%371.96M | 193.76%371.96M | ---- | 56.54%349.14M | 18.10%126.62M | 18.10%126.62M | ---- | 30.59%223.04M |
Financing cost | ---- | -66.76%-209.42M | -68.43%-92.39M | -68.43%-92.39M | ---- | -14.02%-125.58M | 1.77%-54.85M | 1.77%-54.85M | ---- | -50.40%-110.14M |
Share of profits of associates | ---- | -76.31%28.79M | 25.82%64.43M | 25.82%64.43M | ---- | -51.91%121.52M | --51.21M | -39.98%51.21M | ---- | 34.87%252.68M |
Special items of earning before tax | -62.62%72.01M | 720.85%273.75M | 190.72%345M | 2,104.19%264.57M | 404.54%192.63M | -59.43%33.35M | -35.89%118.67M | -47.44%12M | 126.46%38.18M | -41.52%82.19M |
Earning before tax | -73.03%74.41M | -46.37%1.19B | -47.66%939.47M | -36.25%771.65M | -51.94%275.91M | 20.31%2.21B | 48.48%1.79B | 47.26%1.21B | 305.76%574.15M | 149.57%1.84B |
Tax | -23.98%-10.9M | -290.15%-62.51M | -131.52%-51.8M | -231.85%-40.36M | -76.19%-8.79M | 75.41%-16.02M | -84.47%-22.37M | -679.19%-12.16M | 80.49%-4.99M | 4.60%-65.17M |
After-tax profit from continuing operations | -76.22%63.52M | -48.82%1.12B | -49.92%887.67M | -38.97%731.29M | -53.07%267.12M | 23.82%2.2B | 48.11%1.77B | 45.41%1.2B | 390.97%569.16M | 165.31%1.78B |
Earning after tax | -76.22%63.52M | -48.82%1.12B | -49.92%887.67M | -38.97%731.29M | -53.07%267.12M | 23.82%2.2B | 48.11%1.77B | 45.41%1.2B | 390.97%569.16M | 165.31%1.78B |
Minority profit | -122.98%-8.28M | -41.49%222.41M | -53.02%159.82M | -58.84%97.43M | -70.46%36.02M | 418.22%380.14M | 1,082.28%340.2M | 1,144.92%236.68M | 383.90%121.93M | 257.92%73.36M |
Profit attributable to shareholders | -68.93%71.79M | -50.35%902.53M | -49.19%727.85M | -34.08%633.86M | -48.33%231.1M | 6.82%1.82B | 22.63%1.43B | 13.57%961.56M | 181.49%447.23M | 137.83%1.7B |
Basic earnings per share | -66.67%0.01 | -52.17%0.11 | -50.00%0.09 | -33.33%0.08 | -50.00%0.03 | 4.55%0.23 | 20.00%0.18 | 9.09%0.12 | 200.00%0.06 | 100.00%0.22 |
Diluted earnings per share | -66.67%0.01 | -52.17%0.11 | -50.00%0.09 | -33.33%0.08 | -50.00%0.03 | 9.52%0.23 | 20.00%0.18 | 9.09%0.12 | 200.00%0.06 | 90.91%0.21 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young (Special General Partnership), Ernst & Young | -- | -- | -- | Ernst & Young (Special General Partnership), Ernst & Young | -- | -- | -- | Ernst & Young (Special General Partnership), Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data